---
title: "Valrubicin - Malignant tumor of urinary bladder - 2"
sidebar: mydoc_sidebar
permalink: db00385-mesh-d001749-2.html
toc: false 
---


Path ID: `DB00385_MESH_D001749_2`
{% include image.html url="images/db00385-mesh-d001749-2.png" file="db00385-mesh-d001749-2.png" alt="db00385-mesh-d001749-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C016163 | Valrubicin | Drug |
| InterPro:IPR017892 | protein kinase C | GeneFamily |
| GO:0006351 | transcription | BiologicalProcess |
| CL:0001063 | tumor cell | Cell |
| MESH:D001749 | Malignant tumor of urinary bladder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Valrubicin | DECREASES ACTIVITY OF | Protein Kinase C |
| Protein Kinase C | NEGATIVELY REGULATES | Transcription |
| Transcription | LOCATED IN | Tumor Cell |
| Tumor Cell | CORRELATED WITH | Malignant Tumor Of Urinary Bladder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00385#mechanismofaction](https://go.drugbank.com/drugs/DB00385#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Valrubicin](https://pubchem.ncbi.nlm.nih.gov/compound/Valrubicin)

Reference: 
  - [https://go.drugbank.com/drugs/DB00385#mechanismofaction](https://go.drugbank.com/drugs/DB00385#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Valrubicin](https://pubchem.ncbi.nlm.nih.gov/compound/Valrubicin)
